Treatment of Oral Thrush
For oral thrush, topical antifungal agents are recommended for mild disease, while oral fluconazole is the treatment of choice for moderate to severe cases. 1
Treatment Algorithm Based on Disease Severity
Mild Oral Thrush
- Clotrimazole troches, 10 mg 5 times daily for 7-14 days (first-line therapy) 1
- Miconazole mucoadhesive buccal 50-mg tablet applied to the mucosal surface over the canine fossa once daily for 7-14 days (alternative first-line) 1
- Nystatin suspension (100,000 U/mL) 4-6 mL 4 times daily for 7-14 days (alternative) 1, 2
- Nystatin pastilles (200,000 U each) 1-2 pastilles 4 times daily for 7-14 days (alternative) 1
Moderate to Severe Oral Thrush
- Oral fluconazole, 100-200 mg daily for 7-14 days (first-line therapy) 1
- Treatment duration should be continued until clinical resolution of symptoms 1
Fluconazole-Refractory Disease
- Itraconazole solution, 200 mg once daily for up to 28 days 1
- Posaconazole suspension, 400 mg twice daily for 3 days then 400 mg daily for up to 28 days 1
- Voriconazole, 200 mg twice daily 1
- Amphotericin B deoxycholate oral suspension, 100 mg/mL 4 times daily 1
For Patients Unable to Tolerate Oral Therapy
- Intravenous fluconazole, 400 mg (6 mg/kg) daily 1
- Intravenous echinocandin (caspofungin: 70-mg loading dose, then 50 mg daily; micafungin: 100 mg daily; or anidulafungin: 200-mg loading dose, then 100 mg daily) 1
- Intravenous amphotericin B deoxycholate, 0.3 mg/kg daily (less preferred alternative) 1
Special Considerations
Denture-Related Candidiasis
- Disinfection of the denture in addition to antifungal therapy is essential for successful treatment 1
- Remove dentures at night and clean thoroughly 1
HIV-Infected Patients
- Antiretroviral therapy is strongly recommended to reduce the incidence of recurrent infections 1
- May require longer treatment courses or higher doses of antifungal medications 1
- Single-dose fluconazole may be insufficient; follow standard treatment regimens 3, 4
Recurrent Oral Thrush
- For patients with recurrent infection requiring chronic suppressive therapy, fluconazole 100 mg three times weekly is recommended 1
- Investigate for underlying immunodeficiency or other predisposing factors 5
Evidence Strength and Clinical Pearls
- Fluconazole has demonstrated superior clinical cure rates compared to clotrimazole troches in HIV patients with oral thrush, with better patient compliance due to once-daily dosing 6
- In infants, fluconazole suspension (3 mg/kg daily for 7 days) has shown 100% clinical cure rates compared to only 32% with nystatin suspension 7
- Single-dose fluconazole (150 mg) has shown 96.5% improvement in palliative care patients with oral thrush, offering a convenient option for patients with high pill burden 3
- Treatment-resistant thrush may indicate underlying immunodeficiency or fluconazole-resistant Candida strains and warrants further investigation 5, 4
- Fluconazole resistance is increasingly reported and can lead to treatment failure and progression to invasive candidiasis in immunocompromised patients 4
Monitoring and Follow-up
- Clinical response should be evident within 48-72 hours of initiating therapy 3
- If no improvement after 7-14 days of appropriate therapy, consider fluconazole-resistant Candida species and switch to alternative agents 1, 4
- For denture wearers, ensure proper denture hygiene and fit to prevent recurrence 1